Duke University Medical Center - Division of Hematologic Malignancies is a clinical research site located in Durham, North Carolina, United States 27705.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Duke University Medical Center - Division of Hematologic Malignancies has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma, High Grade B-cell Lymphoma (HGBCL).
Sponsors: Miltenyi Biomedicine GmbH.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Duke University Medical Center - Division of Hematologic Malignancies has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Duke University Medical Center - Division of Hematologic Malignancies has 1 clinical trials on record, with 1 currently active. Their work covers Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma, High Grade B-cell Lymphoma (HGBCL).
Duke University Medical Center - Division of Hematologic Malignancies has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.